Top Markets
Coin of the day
Genenta Science S.p.A. Genenta Science S.p.A.

Genenta Science S.p.A.

GNTA
株式のランク #28059
Genenta Science S.p.A. is an Italian clinical-stage biotechnology firm focused... Genenta Science S.p.A. is an Italian clinical-stage biotechnology firm focused on pioneering hematopoietic stem cell gene therapies to combat solid tumors. Its primary therapeutic candidate, Temferon, is currently undergoing Phase 1/2a clinical evaluation. This innovative therapy is being developed to treat glioblastoma multiforme, specifically targeting patients whose tumors exhibit an unmethylated MGMT gene promoter. Beyond this, Genenta Science is exploring Temferon's potential application in various other solid tumor types, including locally advanced hepatocellular carcinoma and intra-hepatic cholangiocarcinoma. Established in 2014, the company maintains its headquarters in Milan, Italy.
株価
$1.51
最終同期: 2026-07-31
時価総額
$28.82M
変化(1日)
-0.33%
変化(1年)
-57.49%
IT
取引 Genenta Science S.p.A. (GNTA)

カテゴリー

Genenta Science S.p.A.(GNTA)の株価履歴
終値の最高値: $1.55 (2026-07-01)

終値の最安値: $11.33 (2021-12-01)
Genenta Science S.p.A. の株価履歴(2021 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 7.52%
2025 -68.48%
2024 -0.35%
2023 -6.83%
2022 -51.72%
2021 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$122.11 -14.02%
AU
$753.28 5.84%
CH